摘要
目的观察早期急性心肌梗塞静脉溶栓治疗的临床疗效。方法选取我院2016年3月至2017年3月接受的64例早期急性心肌梗塞患者为本次实验研究对象,按照是否给予静脉溶栓治疗将所有患者均分为治疗组与对照组,对照组32例患者给予阿司匹林、波立维等常规西药治疗,治疗组32例患者给予尿激酶静脉溶栓治疗,比较两组患者治疗1小时、12小时血管再通率、血管未通率以及不良症状发生情况。结果治疗组患者治疗6个小时、12个小时血管再通率明显优于对照组,治疗组患者病死率以及不良症状发生率明显低于对照组,两组患者各项数据差异具有统计学意义(P<0.05)。结论对于早期急性心肌梗塞患者给予静脉溶栓治疗可有效提高血管再通率,对降低个体患者死亡率、不良症状的发生具有重要的意义。
Objective To investigate the clinical effect of intravenous thrombolysisin the treatment of early-stage acute myocardial infarction. Methods Atotal of 64 patients with early-stage acute myocardial infarction who were admitted to our hospital from March 2016 to March 2017 were enrolled, and according to whether intravenous thrombolysis was preformed, these patients were divided into treatment group and control group, with 32 patients in each group. The patients in the control group were given conventional Western medicine treatment with aspirin and Plavix, and those in the treatment group were given intravenous thrombolysiswithurokinase. The two groups were compared in terms of revascularization rate at 1 and 12 hours of treatment, non-revascularization rate, and incidence of adverse events.Results At 6 and 12 hours of treatment, the treatment group had a significantly higher revascularization rate than the control group（P〈0.05）; the treatment group had significantlylower mortality rate and incidence rate of adverse events than the control group（P 〈0.05）. Conclusion As for patients with early-stage acute myocardial infarction, intravenous thrombolysis can effectively improve revascularization rate and reduce mortality rate and incidence of adverse events.
出处
《心血管病防治知识（学术版）》
2018年第2期26-28,共3页
Prevention and Treatment of Cardiovascular Disease
关键词
早期
急性心肌梗塞
静脉溶栓
临床疗效
Early-stage
Acute myocardial infarction
Intravenous thrombolysis
Clinical effect
